Proton beam therapy for early-stage testicular cancer
Part of Cancer clinical trials.
This trial tests whether proton beam radiation (a precise form of cancer treatment) can effectively treat early-stage testicular cancer that has spread to nearby lymph nodes while reducing side effects. You would receive this specialized radiation after surgery to remove the testicle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male and at least 18 years old
- You have been diagnosed with seminoma (a type of testicular cancer) that has spread to lymph nodes in your abdomen, but the nodes are small (≤3 cm)
- You have already had surgery to remove the affected testicle
- You have not received radiation therapy to your belly or pelvis before
- You are in good overall health with no severe ongoing medical conditions
- You are able and willing to sign a consent form agreeing to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether you can have less intense treatment (“de-escalation”) while still treating a small, limited-stage testicular seminoma that is growing. It may help reduce side effects if you qualify.
This Phase 2 study tests a treatment plan guided by a PET scan over time in people with seminoma after testicle removal. It aims to tailor therapy based on how cancer shows up on the scan, potentially helping avoid unnecessary treatment intensity.
This trial is testing whether removing affected lymph nodes with surgery (RPLND) works well alone for seminoma testicular cancer that has spread to nearby nodes but is still relatively small. It is for patients who have not had extensive chemo or radiation.
This trial tests lowering the intensity of treatment (de-escalation) for Stage II seminoma, a type of testicular cancer. You may receive either a surgery to remove lymph nodes or a single round of chemotherapy (carboplatin), instead of more aggressive standard treatments, to see if it's safe and effective.
This trial tests proton radiation therapy for people with high-risk prostate cancer. It may help by delivering radiation in a more targeted way, with the goal of controlling the cancer while reducing exposure to nearby healthy tissue.
This trial checks whether a specific treatment approach works better for men with higher-risk non-seminomatous germ-cell tumors that have spread. Doctors will use tumor marker changes and where the cancer started (often the chest area) to help guide treatment choices.
Hear when a new Seminoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.